Autologous Transplantation for Parkinson's Disease Patients: Feasibility and Challenge
Neurosci Bull
.
2021 Jul;37(7):1085-1086.
doi: 10.1007/s12264-021-00712-w.
Epub 2021 May 27.
Authors
Qi Zhang
#
1
2
,
Yanlin Wang
#
1
,
Yukai Wang
3
4
5
6
,
Han Liu
1
,
Huifang Sun
1
2
,
Zhuoya Wang
1
,
Changhe Shi
1
,
Jing Yang
1
,
Yuming Xu
7
Affiliations
1
Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
2
Academy of Medical Sciences, Zhengzhou University, Zhengzhou, 450052, China.
3
State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China.
4
Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, 100101, China.
5
Department of National Stem Cell Resource Center, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China.
6
Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, 100101, China.
7
Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
[email protected]
.
#
Contributed equally.
PMID:
34043111
PMCID:
PMC8275752
DOI:
10.1007/s12264-021-00712-w
No abstract available
MeSH terms
Feasibility Studies
Humans
Parkinson Disease* / surgery
Transplantation, Autologous